Concord Drugs Ltd.
BSE: 538965 | Sector: Health care |
NSE: N.A. | ISIN Code: INE858L01010 |
BSE 00:00 | 24 Jun | 21.25 |
-3.10 (-12.73%) |
OPEN
26.40 |
HIGH
26.40 |
LOW
19.50 |
NSE 05:30 | 01 Jan | Concord Drugs Ltd |
OPEN | 26.40 |
PREVIOUS CLOSE | 24.35 |
VOLUME | 5280 |
52-Week high | 37.40 |
52-Week low | 19.50 |
P/E | 11.68 |
Mkt Cap.(Rs cr) | 19 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Concord Drugs Ltd. (CONCORDDRUGS) - Financial Overview
Particulars (![]() |
2021 | 2020 | 2019 |
Net Sales | 51.36 | 51.34 | 48.08 |
Operating Profit | 7.08 | 3.46 | 3.74 |
Other Income | 3.86 | 0.12 | 0.09 |
Interest | 1.42 | 1.54 | 1.59 |
Depreciation | 1.37 | 1.46 | 1.71 |
Profit Before Tax | 4.29 | 0.46 | 0.44 |
Tax | 1.01 | 0.13 | 0.03 |
Profit After Tax | 3.28 | 0.33 | 0.41 |
Share Capital | 8.74 | 8.74 | 7.86 |
Reserves | 18.02 | 14.74 | 15.29 |
Net Worth | 26.76 | 23.48 | 23.15 |
Loans | 15.42 | 12.11 | 12.54 |
Gross Block | 35.22 | 30.98 | 30.84 |
Investments | 0.00 | 0.00 | 0.00 |
Cash | 0.06 | 0.04 | 0.18 |
Debtors | 20.73 | 25.45 | 48.43 |
Net Working Capital | 28.37 | 24.08 | 23.55 |
Operating Profit Margin (%) | 13.79 | 6.74 | 7.78 |
Net Profit Margin (%) | 6.39 | 0.64 | 0.85 |
Earning Per Share (Rs) | 3.75 | 0.38 | 0.52 |
Dividend (%) | 0.00 | 0.00 | 0.00 |
Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices